
Cardinal Health, Inc.
CAHNYSEHealthcareMedical - Distribution
Latest quote
$235.27
+$2.82 · +1.21%
CAH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
42
Fair Value
Momentum
58
Neutral
Sentiment
62
Bullish
Risk resilience
87
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteCardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Jason Hollar
- Listed since
- Aug 4, 1983
- Employees
- 61,344
Market position
- Volume
- 504.15K
- 0.22× average
- Average volume
- 2.26M
- Average daily volume
- Market cap
- 55.08B USD
- Beta
- 0.52
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 61.16B USD
- P/E (TTM)
- 32.35×
- P/B (TTM)
- -19.25×
- P/S (TTM)
- 0.22×
- EV / EBITDA
- 17.58×
- Earnings yield
- 3.06%
- Free cash flow yield
- 8.07%
- Dividend yield
- 0.87%
Profitability & efficiency
- Gross margin
- 3.84%
- Operating margin
- 1.03%
- Net margin
- 0.67%
- Return on equity
- -59.45%
- Return on assets
- 2.99%
- Return on invested capital
- 13.24%
Financial health
- Debt / equity
- -3.45×
- Current ratio
- 0.88×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 254.25B USD | 222.58B USD | 226.83B USD | 204.98B USD | 181.33B USD |
| Cost of goods sold | 244.47B USD | 214.41B USD | 219.41B USD | 198.11B USD | 174.84B USD |
| Gross profit | 9.77B USD | 8.17B USD | 7.41B USD | 6.89B USD | 6.48B USD |
| Selling, general, and administrative | 6.13B USD | 5.38B USD | 5B USD | 4.8B USD | 4.51B USD |
| Operating expenses | 7.16B USD | 5.89B USD | 6.17B USD | 6.12B USD | 7.09B USD |
| Interest expense | 348M USD | 215M USD | 51M USD | 84M USD | 147M USD |
| Depreciation and amortization | 956M USD | 790M USD | 710M USD | 692M USD | 692M USD |
| Operating income | 2.61B USD | 2.28B USD | 1.24B USD | 752M USD | −607M USD |
| Net income | 1.71B USD | 1.56B USD | 852M USD | 330M USD | −938M USD |
Company facts updated Aug 25, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$273.22
16.17% upsideCorporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Apr 23, 2001 | 3:2 | — | — |
Stock split | Nov 2, 1998 | 3:2 | — | — |
Stock split | Dec 17, 1996 | 3:2 | — | — |
Stock split | Jul 1, 1994 | 5:4 | — | — |
Stock split | Oct 1, 1991 | 5:4 | — | — |
Stock split | Oct 1, 1990 | 5:4 | — | — |
Effective Apr 23, 2001
3:2
Effective Nov 2, 1998
3:2
Effective Dec 17, 1996
3:2
Effective Jul 1, 1994
5:4
Effective Oct 1, 1991
5:4
Effective Oct 1, 1990
5:4
CAH peers
ETFs holding CAH
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.72B0.07%2.3T USD0.03%$377.88+0.21%
Vanguard S&P 500 ETFVOO1.41B0.08%1.7T USD0.03%$703.53+0.24%
Vanguard Morningstar Mid-Cap ETFVO1.17B0.52%224.7B USD0.03%$82.7406-0.07%
iShares Core S&P 500 ETFIVV726.66M0.08%881.95B USD0.03%$769.06+0.25%
State Street SPDR S&P 500 ETFSPY677.75M0.08%820.19B USD0.09%$765.42+0.25%
Vanguard Morningstar Value ETFVTV513.07M0.20%256.5B USD0.03%$226.55-0.07%
State Street Health Care Select Sector SPDR ETFXLV390.12M0.86%45.21B USD0.08%$175.44+0.42%
Vanguard Morningstar Mid-Cap Value ETFVOE346.82M0.89%38.6B USD0.05%$208.68-0.42%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.72B
- Weight
- 0.07%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.88+0.21%
Vanguard S&P 500 ETFVOO- Market value
- 1.41B
- Weight
- 0.08%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.53+0.24%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 1.17B
- Weight
- 0.52%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.7406-0.07%
iShares Core S&P 500 ETFIVV- Market value
- 726.66M
- Weight
- 0.08%
- AUM
- 881.95B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.06+0.25%
State Street SPDR S&P 500 ETFSPY- Market value
- 677.75M
- Weight
- 0.08%
- AUM
- 820.19B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.42+0.25%
Vanguard Morningstar Value ETFVTV- Market value
- 513.07M
- Weight
- 0.20%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.55-0.07%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 390.12M
- Weight
- 0.86%
- AUM
- 45.21B USD
- Expense ratio
- 0.08%
- Price / 1D
- $175.44+0.42%
Vanguard Morningstar Mid-Cap Value ETFVOE- Market value
- 346.82M
- Weight
- 0.89%
- AUM
- 38.6B USD
- Expense ratio
- 0.05%
- Price / 1D
- $208.68-0.42%
Continue in GoAI
Research CAHresearch.disclaimer





